Avoid Unapproved Potassium Phosphates Injection in Pediatric Patients

The FDA has issued a safety alert regarding the use of unapproved potassium phosphates drug products by Hospira in pediatric patients. These products may result in daily aluminum exposures exceeding recommended limits, potentially leading to various health issues. To prevent this, the FDA recommends using alternative products such as Fresenius Kabi’s or CMP Development’s Potassium…

Read More

White House offers new plan to address drug shortages

The White House has finally released a plan to address drug shortages, linking Medicare payments to hospitals with practices that prevent shortages. A task force was formed in early 2023 to tackle the issue, particularly with cancer drugs shortages. Lawmakers have not been in contact with the task force and are unsure of its leadership….

Read More

Doctors on front line of tackling childhood obesity need more training and resources, say researchers

A study conducted by the University of Birmingham found that healthcare professionals, including doctors and nurses, feel ill-equipped to address the issue of childhood obesity due to a lack of training, time, and resources. Professionals expressed frustration over limited availability of specialist services, lack of training on childhood obesity, and concerns about damaging trust with…

Read More

Microwave ablation offers a promising treatment option for multifocal papillary thyroid cancer

A study published in Radiology found that microwave ablation was as effective as surgery in treating multifocal papillary thyroid carcinoma (PTC) with fewer complications. PTC is the most common type of thyroid cancer and often presents with multiple nodules within the thyroid gland. Microwave ablation showed similar progression-free survival rates to surgery but resulted in…

Read More

What You Should Know Today

In 1996, Doug Olson was diagnosed with chronic lymphocytic leukemia (CLL) and underwent various treatments including chemotherapy. When the cancer stopped responding to treatment, he was recommended CAR T-cell therapy, a type of immunotherapy that reengineers immune cells to target cancer cells more effectively. CAR T-cell therapy has shown promising results for blood cancers, with…

Read More

FDA Clears TriClip for Tricuspid Regurgitation

The FDA has approved Abbott’s TriClip Transcatheter Edge-to-Edge Repair system for repairing severe tricuspid regurgitation. The approval was based on positive results from the TRILUMINATE trial, showing significant improvement in quality of life for patients who underwent repair with the TriClip system. The procedure was found to be safe, with a high rate of patients…

Read More
error: Content is protected !!